Avec un Budget Défense record et des dizaines de milliers de postes à pourvoir, le moment est une opportunité historique pour les formateurs. À condition de bien se positionner.

Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

Cette compétence n’est plus, aujourd’hui, l’apanage des super-héros Marvel. Dans un monde en pleine métamorphose, ...

The tie-up of SpaceX and xAI is all about a plan to dominate space with artificial-intelligence data centers, according to Elon Musk, who founded both companies. It won’t be cheap. Analysts at ...

Executives at DeFi Development (NASDAQ:DFDV) used the company’s monthly business recap and AMA to outline January operational ...

Texas Instruments (TXN) shares were up 6.5% during early market trading on Wednesday following its fourth-quarter results and outlook, which proved the data center buildout is benefitting more than ...

Analysts with Wisconsin's utility regulator question if a new rate plan will protect residents from costs tied to data centers. We Energies has proposed a special rate for data centers, which includes ...

About 97% of Wall Street analysts rate Microsoft stock as a buy, the highest percentage among S&P 500 stocks. One of the major growth catalysts for Microsoft is its AI cloud computing business, which ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...

Multiple media outlets, including the Associated Press, reported that ByteDance has reached an agreement with Oracle ORCL, Silver Lake, and Abu-Dhabi-based MGX to set up a joint venture for TikTok’s ...

A company with $20 billion in annual revenue can’t commit $1.4 trillion to capital infrastructure. It’s simple math: by the end of 2026, market pressure is likely to push OpenAI toward scaling back ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...